Results 11 to 20 of about 88,988 (279)
Edema macular cistoideo Macular cystoid edema
Medisan, 2010 Se presentan 2 casos clínicos de pacientes con edema macular cistoideo, provocado por cirugía intraocular (por extracción extracapsular del cristalino y lente intraocular) y operación convencional del desprendimiento de retina, entre otras causas ...
Blanca Nieve Rey Estévez +2 more
doaj +1 more source
Clinical Ophthalmology, 2008 Tryfon G Rotsos1, Marilita M Moschos21Medical Retina Service, Moorfields Eye Hospital, London, UK; 2Department of Ophthalmology, University of Athens, GreeceAbstract: We review the epidemiology, pathophysiology, and etiology of cystoid macular edema (CME)
Tryfon G Rotsos, Marilita M Moschos
doaj +4 more sources
Eye, 2016 Macular edema may complicate anterior, intermediate, and posterior uveitis, which may be due to various infectious, tumoral, or autoimmune etiologies. Breakdown of the internal or external blood-retinal barrier is involved in the pathogenesis of inflammatory macular edema.
C, Fardeau +3 more
openaire +3 more sources
Ocular Immunology and Inflammation, 2018 Macular edema (ME) is a leading cause of vision loss in both children and adults with uveitis.1–7 Reported rates of uveitic ME (UME) from tertiary referral clinics have ranged from roughly 20% to 3...
Emmett T, Cunningham, Manfred, Zierhut
openaire +2 more sources
Folia Medica, 2015 AIM: To compare spectral-domain optical coherence tomography (SD-OCT) with fluorescein angiography (FA) in detecting macular edema in patients with uveitis and analyse discrepancies in the findings obtained by the two methods. METHODS: The study included
Mitkova-Hristova Vesela T. +4 more
doaj +1 more source
Comparison between “early” or “late” intravitreal injection of dexamethasone implant in branch (BRVO) or central (CRVO) retinal vein occlusion: six months follow-up [PDF]
, 2017 AIM: The aim of this study was to compare early and late injections of intravitreal dexamethasone implant in patients affected by central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO) with a six-months follow-up.
AUTOLITANO, MONICA +6 more
core +1 more source
Adverse events associated with intraocular injection of anti-VEGF(bevacizumab) in retinal vein ccclusion: a case report [PDF]
, 2015 Introduction: Antiangiogenic agents are often administered for treatment of Branch Retinal Vein Occlusion (BRVO). Among them, Bevacizumab has noticeable antiangiogenic and antiedemigenic properties and possesses great capacity to penetrate the retinal ...
ARTICO, Marco +7 more
core +1 more source
Visual acuity and macular thickness in diabetic retinopathy treated with panphotocoagulation [PDF]
, 2008 OBJETIVO: Comparar espessura macular e acuidade visual em pacientes portadores de retinopatia diabética, com e sem edema de mácula, submetidos à panfotocoagulação retiniana com laser de argônio.
MAIA JÚNIOR, Otacílio de Oliveira +2 more
core +2 more sources
Acute onset of fingolimod-associated macular edema
American Journal of Ophthalmology Case Reports, 2016 Purpose: Fingolimod is among the first oral disease-modifying agents for the treatment of relapsing-remitting multiple sclerosis (MS). Despite its favorable safety profile, fingolimod may cause macular edema, a significant adverse event, which occurs ...
Mohamed Kamel Soliman +7 more
doaj +1 more source
Integrated results from the COPERNICUS and GALILEO studies. [PDF]
, 2017 OBJECTIVES: To report on the efficacy and safety of intravitreal aflibercept in patients with macular edema secondary to central retinal vein occlusion (CRVO) in an integrated analysis of COPERNICUS and GALILEO.
Ahlers, Christiane +13 more
core +3 more sources